Search research articles
Contact Us
Filters
Showing results (121-130 of 169) with videos related to
Page
of 17
Sort By:
Cancer
|
October 22, 2015
Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas
Yasumasa Yoshioka, Yosuke Togashi, Takaaki Chikugo, et al.
Cancer Medicine
|
August 4, 2025
Real-World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma
Eiji Nakata, Daisuke Ennishi, Tatsunori Osone, et al.
International Journal of Proteomics
|
June 8, 2012
Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis
Kiyoshi Yanagisawa, Shuta Tomida, Keitaro Matsuo, et al.
Cancer Research Communications
|
March 11, 2026
Constitutive EGFR activation induced by PTPRR downregulation confers resistance to KRAS inhibitors
Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi, et al.
Scientific Reports
|
June 24, 2021
Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
Makoto Nakamura, Yusuke Meguri, Shuntaro Ikegawa, et al.
Molecular Cancer Therapeutics
|
May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation
Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi, et al.
Cancer Research Communications
|
January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG study
Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Biochemical and Biophysical Research Communications
|
August 2, 2020
Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer
Kosuke Ochi, Ken Suzawa, Shuta Tomida, et al.
Scientific Reports
|
May 4, 2022
One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study
Kei Namba, Ken Suzawa, Kazuhiko Shien, et al.
Molecular Cancer Therapeutics
|
September 26, 2014
MEK inhibitor for gastric cancer with MEK1 gene mutations
Shunsuke Sogabe, Yosuke Togashi, Hiroaki Kato, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 169) with videos related to
Sort By:
Page
of 17
Cancer
|
October 22, 2015
Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas
Yasumasa Yoshioka, Yosuke Togashi, Takaaki Chikugo, et al.
Cancer Medicine
|
August 4, 2025
Real-World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma
Eiji Nakata, Daisuke Ennishi, Tatsunori Osone, et al.
International Journal of Proteomics
|
June 8, 2012
Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis
Kiyoshi Yanagisawa, Shuta Tomida, Keitaro Matsuo, et al.
Cancer Research Communications
|
March 11, 2026
Constitutive EGFR activation induced by PTPRR downregulation confers resistance to KRAS inhibitors
Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi, et al.
Scientific Reports
|
June 24, 2021
Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
Makoto Nakamura, Yusuke Meguri, Shuntaro Ikegawa, et al.
Molecular Cancer Therapeutics
|
May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation
Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi, et al.
Cancer Research Communications
|
January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG study
Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Biochemical and Biophysical Research Communications
|
August 2, 2020
Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer
Kosuke Ochi, Ken Suzawa, Shuta Tomida, et al.
Scientific Reports
|
May 4, 2022
One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study
Kei Namba, Ken Suzawa, Kazuhiko Shien, et al.
Molecular Cancer Therapeutics
|
September 26, 2014
MEK inhibitor for gastric cancer with MEK1 gene mutations
Shunsuke Sogabe, Yosuke Togashi, Hiroaki Kato, et al.
Page
of 17